{"database": "lobbying", "table": "lobbying_activities", "rows": [[2182349, "f20c9597-84bf-44dc-b3bc-ef3de7a0a942", "Q3", "CAPITOL HILL CONSULTING GROUP", 72053, "PURDUE PHARMA LLP", 2018, "third_quarter", "PHA", "Controlled Drug Substances Act (21 USC 13)", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2018-10-11T11:08:03.083000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2182349"], "units": {}, "query_ms": 75.99716197000816, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}